ArticleCancer research2015

Amphiregulin Is a Critical Downstream Effector of Estrogen Signaling in ERα-Positive Breast Cancer.

Esther A Peterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.